Khan and Maloney

Decentralized Clinical Trials: Considerations for Implementation

By Myla Maloney, MBA, BCMAS, Yosef Khan, MD, MPH, PhD
No Comments
Khan and Maloney

Randomized clinical trials are the gold standard for conducting clinical research. They are, however, fraught with issues and come with burdens to the patient, site and sponsor. Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology. Here’s how to determine if a full or hybrid DCT is a good option for your clinical trial.

Continue reading

CuePath Blister Pack

Smart Solutions To Improve Patient Compliance

By Ken Piaggio, Vinay Gokhale
No Comments
CuePath Blister Pack

Numerous studies have explored the challenge of helping patients adhere to their medication regimens. One promising solution is “smart” medication blister packs with embedded sensors that enable caregivers to remotely monitor if—and when—doses are removed. But they can only be used if they are cyber-hardened against today’s dangerous and ever-evolving cybersecurity risks.

Continue reading

Rogers-Headshot

The Rise of Digital Therapeutics

By Brian C. Rogers
No Comments
Rogers-Headshot

Digital therapeutics (DTx) have the potential to lower healthcare costs and improve patient compliance, outcomes and access to care. In the first part of this two-article series we look at the current and potential applications for this growing sector of digital health as well as key considerations for technology developers.

Continue reading